| | | | | | | | | | | | | | | | | | | | | | |
Ownership Document
|
| Schema Version: X0508 |
| Document Type: 4 |
| Period of Report: 10/10/23 |
| Not Subject to Section 16: 0 |
| Issuer: |
| Issuer CIK: 1427925 |
| Issuer Name: ACELRX PHARMACEUTICALS INC |
| Issuer Trading Symbol: ACRX |
| Reporting Owner: |
| Reporting Owner ID: |
| | Owner CIK: 1594021 |
| | Owner Name: Afable Richard |
| Reporting Owner Address: |
| | Owner Street 1: C/O ACELRX PHARMACEUTICALS, INC. |
| | Owner Street 2: 1850 GATEWAY DRIVE, SUITE 175 |
| | Owner City: SAN MATEO |
| | Owner State: CA |
| | Owner ZIP Code: 94404 |
| | Owner State Description: |
| Reporting Owner Relationship: |
| | Is Director? Yes |
| | Is Officer? No |
| | Is Ten Percent Owner? No |
| | Is Other? No |
| Aff 10b5 One: 0 |
| Non-Derivative Table: |
| Non-Derivative Transaction: |
| | Security Title: |
| | | Value: Common Stock |
| | | Footnote ID: F1 |
| | Transaction Date: |
| | | Value: 10/10/23 |
| | Deemed Execution Date: |
| | Transaction Coding: |
| | | Transaction Form Type: 4 |
| | | Transaction Code: A |
| | | Equity Swap Involved? No |
| | Transaction Timeliness: |
| | | Value: |
| | Transaction Amounts: |
| | | Transaction Shares: |
| Value: 581 |
| Footnote ID: F2 |
| | | Transaction Price Per Share: |
| Value: 0.00 |
| | | Transaction Acquired-Disposed Code: |
| Value: A |
| | Post-Transaction Amounts: |
| | | Shares Owned Following Transaction: |
| Value: 2,468 |
| Footnote ID: F3 |
| | Ownership Nature: |
| | | Direct or Indirect Ownership: |
| Value: D |
| Derivative Table: |
| Derivative Transaction: |
| | Security Title: |
| | | Value: Stock Option (Right to Buy) |
| | Conversion or Exercise Price: |
| | | Value: 0.684 |
| | Transaction Date: |
| | | Value: 10/10/23 |
| | Deemed Execution Date: |
| | Transaction Coding: |
| | | Transaction Form Type: 4 |
| | | Transaction Code: A |
| | | Equity Swap Involved? No |
| | Transaction Timeliness: |
| | | Value: |
| | Transaction Amounts: |
| | | Transaction Shares: |
| Value: 3,487 |
| | | Transaction Price Per Share: |
| Value: 0.00 |
| | | Transaction Acquired-Disposed Code: |
| Value: A |
| | Exercise Date: |
| | | Value: 10/10/24 |
| | | Footnote ID: F4 |
| | Expiration Date: |
| | | Value: 10/10/33 |
| | Underlying Security: |
| | | Underlying Security Title: |
| Value: Common Stock |
| | | Underlying Security Shares: |
| Value: 3,487 |
| | Post-Transaction Amounts: |
| | | Shares Owned Following Transaction: |
| Value: 3,487 |
| | Ownership Nature: |
| | | Direct or Indirect Ownership: |
| Value: D |
| Footnotes: |
| Footnote - F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
| Footnote - F2: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. |
| Footnote - F3: Effective on October 25, 2022, the issuer effected a 20 to 1 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split. |
| Footnote - F4: 100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. |
| Remarks: |
| Owner Signature: |
| Signature Name: /s/ Martha Adler, Attorney-In-Fact |
| Signature Date: 12/13/23 |
